EICHOR
● Active Not Recruiting
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years
Condition: Irritable Bowel Syndrome With Constipation (IBS-C) · Sponsor: Ardelyx
About this study
This is a randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of tenapanor (25 mg and 50 mg) in pediatric patients (≥12 and \<18 years old) with IBS-C when administered twice daily (BID) for 12 consecutive weeks.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (39)
| G & L Research, LLC | Foley, Alabama, United States | — |
| Eclipse Clinical Research | Tucson, Arizona, United States | — |
| Applied Research Center of Arkansas | Little Rock, Arkansas, United States | — |
| Advanced Research Center, Inc. | Anaheim, California, United States | — |
| Connecticut Children's Medical Center | Hartford, Connecticut, United States | — |
| Prohealth Research Center | Doral, Florida, United States | — |
| I.H.S. Health, LLC | Kissimmee, Florida, United States | — |
| Waterway Research & Associates Corp | Miami, Florida, United States | — |
| Valencia Medical and Research Center | Miami, Florida, United States | — |
| Orlando Health, Inc.- APH Center for Digestive Health and Nutrition | Orlando, Florida, United States | — |
| Florida Pharmaceutical Research and Associates, Inc. | South Miami, Florida, United States | — |
| Clinical Research Institute | Stockbridge, Georgia, United States | — |
+ 27 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05643534